Characterization of differences between rapid agonist-dependent phosphorylation and phorbol ester-mediated phosphorylation of human substance P receptor in intact cells
Ed. Roush et al., Characterization of differences between rapid agonist-dependent phosphorylation and phorbol ester-mediated phosphorylation of human substance P receptor in intact cells, MOLEC PHARM, 55(5), 1999, pp. 855-862
Substance P receptor (SPR), which plays a key role in pain transmission, is
known to undergo rapid agonist-dependent desensitization and internalizati
on. The present study shows that human SPR undergoes agonist-dependent phos
phorylation in intact cells. Immunoprecipitation of SPR from P-32(i)-labele
d Chinese hamster ovary cells stably expressing human SPR (CHO-hSPR) indica
tes that substance P (SP) causes a rapid (T-1/2 < 1 min), dose-dependent (E
C50 = 2 nM), and pronounced (5-fold over basal) phosphorylation of SPR. Bec
ause SPR in CHO-hSPR couples to G alpha(q), G alpha(s), and G alpha(o), (Ro
ush and Kwatra, 1998), we examined the involvement of various second messen
ger-activated protein kinases in SPR phosphorylation. Although increases in
intracellular cyclic AMP or treatment with the calcium ionophore A23187 do
not cause SPR phosphorylation, treatment with the protein kinase C (PKC) a
ctivator phorbol 12-myristate 13-acetate (PMA) causes a 2.5-fold increase i
n SPR phosphorylation with a T-1/2 of <1 min. However, PKC inhibitor GF1092
03X has no effect on SP-dependent SPR phosphorylation. Furthermore, althoug
h SP treatment phosphorylates SPR on both serine and threonine residues equ
ally, PMA treatment phosphorylates the receptor predominantly on serine res
idues. Two-dimensional phosphopeptide mapping data indicate that SP-depende
nt and PMA-dependent phosphorylations of SPR have some unique differences,
Taken together, these data suggest that although activation of PKC by PMA c
an lead to SPR phosphorylation, PKC does not mediate SP-dependent phosphory
lation of SPR. In conclusion, the present study represents the first demons
tration and characterization of agonist-dependent and PMA-mediated phosphor
ylation of SPR in intact cells.